Serum adiponectin in gestational diabetes and its relation to pregnancy outcome

Journal of Obstetrics and Gynaecology

Volumn 34, Issue 6, 2014, Pages 471-475

  Doruk, M ^a   Ugur M ^a   Oruc A S ^a   Demirel, N ^a   Yildiz, Y ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Adiponectin; Adverse pregnancy outcomes; Gestational diabetes mellitus

Indexed keywords

ADIPONECTIN; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ADVERSE OUTCOME; ARTICLE; BODY MASS; CHOLESTASIS; CONTROLLED STUDY; DELIVERY; DIET RESTRICTION; DYSTOCIA; FEMALE; FETUS DISTRESS; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYDRAMNIOS; INCISION; MACROSOMIA; MAJOR CLINICAL STUDY; OLIGOHYDRAMNIOS; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT GAIN; BLOOD; CASE CONTROL STUDY; CESAREAN SECTION; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TURKEY; YOUNG ADULT;

ADIPONECTIN; ADULT; CASE-CONTROL STUDIES; CESAREAN SECTION; DIABETES, GESTATIONAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; TURKEY; YOUNG ADULT;

EID: 84905050647     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2014.902430     Document Type: Article

References (33)

1. Agarwal MM, Hughes PF, Punnose J, Ezimokhai M, Thomas L. 2001. Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins. Diabetes Research and Clinical Practice 51: 67-73.
2. Altinova AE, Toruner F, Bozkurt N, Bukan N, Karakoc A, Yetkin I et al. 2007. Circulating concentrations of adiponectin and tumor necrosis factoralpha in gestational diabetes mellitus. Gynecological Endocrinology 23: 161-165.
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257: 79-83.
4. Blüher M, Fasshauer M, Tönjes A, Kratzsch J, Schön MR, Paschke R. 2005. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Experimental and Clinical Endocrinology and Diabetes 113: 534-537.
5. Carpenter MW, Coustan DR. 1982. Criteria for screening tests for gestational diabetes. American Journal of Obstetrics and Gynecology 144: 768-773.
6. Chan TF, Yuan SS, Chen HS, Guu CF, Wu LC, Yeh YT et al. 2004. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstetricia et Gynecologica Scandinavica 83: 165-169.
7. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V et al. 2007. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clinical Endocrinology (Oxford) 66: 447-453.
8. Cseh K, Baranyi E, Melczer Z, Kaszás E, Palik E, Winkler G. 2004. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 27: 274-275.
9. Díez JJ, Iglesias P. 2003. The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology 148: 293-300.
10. Horosz E, Bomba-Opon DA, Szymanska M, Wielgos M. 2011. Third trimester plasma adiponectin and leptin in gestational diabetes and normal pregnancies. Diabetes Research and Clinical Practice 93: 350-356.
11. Kinalski M, Telejko B, Kuźmicki M, Kretowski A, Kinalska I. 2005. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Hormone and Metabolic Research 37: 450-454.
12. Kyriakakou M, Malamitsi-Puchner A, Militsi H, Boutsikou T, Margeli A, Hassiakos D et al. 2008. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers. European Journal of Endocrinology 158: 343-348.
13. López-Bermejo A, Fernández-Real JM, Garrido E, Rovira R, Brichs R, Genaró P et al. 2004. Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight. Clinical Endocrinology (Oxford) 61: 544-552.
14. Lowe LP, Metzger BE, Lowe WL Jr, Dyer AR, McDade TW, McIntyre HD. 2010. HAPO Study Cooperative Research Group. Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Journal of Clinical Endocrinology and Metabolism 95: 5427-5434.
15. McLachlan KA, O'Neal D, Jenkins A, Alford FP. 2006. Do adiponectin, TNF alpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes/Metabolism Research and Reviews 22: 131-138.
16. Moore TR. 2004. Diabetes in pregnancy. In: Creasy RK, Resnik R, editors. Maternal-fetal medicine. 5th edn. Philadelphia: WB Saunders. p 1023-1061.
17. Nanda S, Akolekar R, Sarquis R, Mosconi AP, Nicolaides KH. 2011. Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomia. Prenatal Diagnosis 31: 479-483.
18. Ouyang Y, Chen H, Chen H. 2007. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. International Journal of Gynecology and Obstetrics 98: 110-114.
19. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. 2004. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstetricia et Gynecologica Scandinavica 83: 341-347.
20. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. 2004. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27: 799-800.
21. Richardson AC, Carpenter MW. 2007. Inflammatory mediators in gestational diabetes mellitus. Obstetrics and Gynecology Clinics of North America 34: 213-224.
22. Shah BD, Cohen AW, May C, Gabbe SG. 1982. Comparison of glycohemoglobin determination and the one-hour oral glucose screen in the identification of gestational diabetes. American Journal of Obstetrics and Gynecology 144: 774-777.
23. Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R et al. 2003. Adiponectin in human cord blood: relation to fetal birth weight and gender. Journal of Clinical Endocrinology and Metabolism 88: 5656-5660.
24. Soheillykhah S, Mohammadi, Mojibian J, Rahimi-Saghand S, Rashidi M, Hadinedoushan H et al. 2009. Maternal serum adiponectin concentration in gestational diabetes. Gynecological Endocrinology 25: 593-596.
25. Tamás G, Marre M, Astorga R, Dedov I, Jacobsen J, Lindholm A; Insulin Aspart Study Goup. 2001. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. Diabetes Research and Clinical Practice 54: 105-114.
26. Tsai PJ, Yu CH, Hsu SP, Lee YH, Huang IT, Ho SC et al. 2005. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 21: 1095-1099.
27. Weeks JW, Major CA, de Veciana M, Morgan MA. 1994. Gestational diabetes: does the presence of risk factors influence perinatal outcome? American Journal of Obstetrics and Gynecology 171: 1003-1007.
28. Weerakiet S, Lertnarkorn K, Panburana P, Pitakitronakorn S, Vesathada K, Wansumrith S. 2006. Can adiponectin predict gestational diabetes? Gynecological Endocrinology 22: 362-368.
29. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 86: 1930-1935.
30. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D et al. 2004. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27: 1721-1727.
31. Wolfson N, Gavish D, Matas Z, Boaz M, Shargorodsky M. 2012. Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load. Experimental Diabetes Research 2012: 2506-2521.
32. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knöfler M, Bancher-Todesca D. 2004. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 191: 2120-2124.
33. Ylinen K. 1987. High maternal levels of hemoglobin A1c associated with delayed fetal lung maturation in insulin-dependent diabetic pregnancies. Acta Obstetricia et Gynecologica Scandinavica 66: 263-266.